Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies.

about

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies.

Item

http://www.wikidata.org/entity/Q47096270

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effective immunosuppressive ma ...... he presence of CFH antibodies.

@en

Effective immunosuppressive ma ...... he presence of CFH antibodies.

@nl

type

Item

label

Effective immunosuppressive ma ...... he presence of CFH antibodies.

@en

Effective immunosuppressive ma ...... he presence of CFH antibodies.

@nl

prefLabel

Effective immunosuppressive ma ...... he presence of CFH antibodies.

@en

Effective immunosuppressive ma ...... he presence of CFH antibodies.

@nl

P1476

Effective immunosuppressive ma ...... he presence of CFH antibodies.

@en

P2093

Anette Bachmann

http://www.w3.org/2001/XMLSchema#string

Carsten Bergmann

http://www.w3.org/2001/XMLSchema#string

Christof Mayer

http://www.w3.org/2001/XMLSchema#string

Jan Halbritter

http://www.w3.org/2001/XMLSchema#string

Johannes Münch

http://www.w3.org/2001/XMLSchema#string

Maik Grohmann

http://www.w3.org/2001/XMLSchema#string

Michael Kirschfink

http://www.w3.org/2001/XMLSchema#string

Tom H Lindner

http://www.w3.org/2001/XMLSchema#string

P2860

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Expression of complement components differs between kidney allografts from living and deceased donors

A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration

De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.

Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.

The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.

The autoimmune disease DEAP-hemolytic uremic syndrome.

New insights into postrenal transplant hemolytic uremic syndrome.

Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.

Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.

P304

742-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1093/CKJ/SFX053

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29225802

http://www.w3.org/2001/XMLSchema#string

P932

5716210

http://www.w3.org/2001/XMLSchema#string